A Real-World Study of Guselkumab in Chinese Participants With Ulcerative Colitis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Real-World Study of Guselkumab in Chinese Participants With Ulcerative Colitis — Stella

Home/Colitis, Ulcerative/

View on ClinicalTrials.gov

Recruiting

Back to Colitis, Ulcerative trials

Trial locations(1 site)

China

The Second Hospital of Hebei Medical University, Shijiazhuang

Key details

Sponsor

Xian-Janssen Pharmaceutical Ltd.

Enrollment target

~200 participants

Started

December 2025

Primary completion

June 2028

Age range

18 Years and older

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.